Figure 1. Research Method Flow Chart 11
Figure 2. Bottom-up Approach and Top-down Approach for Market Estimation 14
Figure 3. Europe Market Forecast in Optimistic, Conservative and Balanced Perspectives, 2019-2030 16
Figure 4. Europe Organ-on-Chip Market, 2019-2030, $ mn 19
Figure 5. Impact of COVID-19 on Business 22
Figure 6. Primary Drivers and Impact Factors of Europe Organ-on-Chip Market 24
Figure 7. Worldwide Geriatric Population (60 years and above) by Regions, 2015 & 2030, million 27
Figure 8. World Population 65 and Over, % of Total Population, 1950-2060 27
Figure 9. Primary Restraints and Impact Factors of Europe Organ-on-Chip Market 29
Figure 10. Investment Opportunity Analysis 33
Figure 11. Porter’s Fiver Forces Analysis of Europe Organ-on-Chip Market 36
Figure 12. Breakdown of Europe Organ-on-Chip Market by Offering, 2019-2030, % of Revenue 41
Figure 13. Europe Addressable Market Cap in 2021-2030 by Offering, Value ($ mn) and Share (%) 41
Figure 14. Europe Organ-on-Chip Market: Chips, 2019-2030, $ mn 42
Figure 15. Europe Organ-on-Chip Market: Service, 2019-2030, $ mn 43
Figure 16. Breakdown of Europe Organ-on-Chip Market by Organ Type, 2019-2030, % of Sales Revenue 45
Figure 17. Europe Addressable Market Cap in 2021-2030 by Organ Type, Value ($ mn) and Share (%) 45
Figure 18. Europe Organ-on-Chip Market: Liver-on-a-Chip, 2019-2030, $ mn 46
Figure 19. Europe Organ-on-Chip Market: Heart-on-a-Chip, 2019-2030, $ mn 47
Figure 20. Europe Organ-on-Chip Market: Lung-on-a-Chip, 2019-2030, $ mn 48
Figure 21. Europe Organ-on-Chip Market: Kidney-on-a-Chip, 2019-2030, $ mn 49
Figure 22. Europe Organ-on-Chip Market: Brain-on-a-Chip, 2019-2030, $ mn 50
Figure 23. Europe Organ-on-Chip Market: Skin-on-a-Chip, 2019-2030, $ mn 51
Figure 24. Europe Organ-on-Chip Market: Vessels-on-a-Chip, 2019-2030, $ mn 52
Figure 25. Europe Organ-on-Chip Market: Other Organ Types, 2019-2030, $ mn 53
Figure 26. Breakdown of Europe Organ-on-Chip Market by Material, 2019-2030, % of Sales Revenue 55
Figure 27. Europe Addressable Market Cap in 2021-2030 by Material, Value ($ mn) and Share (%) 55
Figure 28. Europe Organ-on-Chip Market: Polymers, 2019-2030, $ mn 56
Figure 29. Europe Organ-on-Chip Market: Glass, 2019-2030, $ mn 57
Figure 30. Europe Organ-on-Chip Market: Silicon, 2019-2030, $ mn 58
Figure 31. Breakdown of Europe Organ-on-Chip Market by Application, 2019-2030, % of Revenue 60
Figure 32. Europe Addressable Market Cap in 2021-2030 by Application, Value ($ mn) and Share (%) 60
Figure 33. Europe Organ-on-Chip Market: Drug Discovery, 2019-2030, $ mn 61
Figure 34. Europe Organ-on-Chip Market: Toxicology Research, 2019-2030, $ mn 62
Figure 35. Europe Organ-on-Chip Market: Other Applications, 2019-2030, $ mn 63
Figure 36. Breakdown of Europe Organ-on-Chip Market by End User, 2019-2030, % of Revenue 65
Figure 37. Europe Addressable Market Cap in 2021-2030 by End User, Value ($ mn) and Share (%) 65
Figure 38. Europe Organ-on-Chip Market: Pharmaceutical and Biotechnology Companies, 2019-2030, $ mn 66
Figure 39. Europe Organ-on-Chip Market: Academic and Research Institutes, 2019-2030, $ mn 67
Figure 40. Europe Organ-on-Chip Market: Cosmetics Industry, 2019-2030, $ mn 68
Figure 41. Europe Organ-on-Chip Market: Other End Users, 2019-2030, $ mn 69
Figure 42. Breakdown of European Organ-on-Chip Market by Country, 2019 and 2030F, % of Revenue 71
Figure 43. Contribution to Europe 2021-2030 Cumulative Revenue by Country, Value ($ mn) and Share (%) 72
Figure 44. Organ-on-Chip Market in Germany, 2019-2030, $ mn 73
Figure 45. Organ-on-Chip Market in U.K., 2019-2030, $ mn 75
Figure 46. Organ-on-Chip Market in France, 2019-2030, $ mn 77
Figure 47. Organ-on-Chip Market in Spain, 2019-2030, $ mn 79
Figure 48. Organ-on-Chip Market in Italy, 2019-2030, $ mn 81
Figure 49. Organ-on-Chip Market in Russia, 2019-2030, $ mn 83
Figure 50. Organ-on-Chip Market in Rest of Europe, 2019-2030, $ mn 85
Figure 51. Growth Stage of Europe Organ-on-Chip Industry over the Forecast Period 87
Europe organ-on-chip market accounted for $6.9 million in 2020 and will grow by 32.2% annually over 2020-2030 owing to the rising use of organ-on-a-chip (OOC) in early detection of drug toxicity, increasing demand for personalized medicine, the emergence of OOC as an alternative to animal testing, the significant increase in research funding and venture capital investments. Highlighted with 33 tables and 51 figures, this 106-page report “Europe Organ-on-Chip Market 2020-2030 by Offering (Chips, Service), Organ Type (Liver, Heart, Lung, Kidney, Brain, Skin), Material (Polymers, Glass, Silicon), Application, End User, and Country: Trend Forecast and Growth Opportunity” is based on a comprehensive research of the entire Europe organ-on-chip market and all its sub-segments through extensively detailed classifications. Profound analysis and assessment are generated from premium primary and secondary information sources with inputs derived from industry professionals across the value chain. The report is based on studies on 2017-2019 and provides estimate for 2020 and forecast from 2021 till 2030 with 2019 as the base year. (Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.) In-depth qualitative analyses include identification and investigation of the following aspects: • Market Structure • Growth Drivers • Restraints and Challenges • Emerging Product Trends & Market Opportunities • Porter’s Fiver Forces The trend and outlook of Europe market is forecast in optimistic, balanced, and conservative view by taking into account of COVID-19. The balanced (most likely) projection is used to quantify Europe organ-on-chip market in every aspect of the classification from perspectives of Offering, Organ Type, Material, Application, End User, and Country. Based on Offering, the Europe market is segmented into the following sub-markets with annual revenue ($ mn) for 2019-2030 included in each section. • Chips • Service Based on Organ Type, the Europe market is segmented into the following sub-markets with annual revenue ($ mn) for 2019-2030 included in each section. • Liver-on-a-Chip • Heart-on-a-Chip • Lung-on-a-Chip • Kidney-on-a-Chip • Brain-on-a-Chip • Skin-on-a-Chip • Vessels-on-a-Chip • Other Organ Types Based on Material, the Europe market is segmented into the following sub-markets with annual revenue ($ mn) for 2019-2030 included in each section. • Polymers • Glass • Silicon Based on Application, the Europe market is segmented into the following sub-markets with annual revenue ($ mn) for 2019-2030 included in each section. • Drug Discovery • Toxicology Research • Other Applications Based on End User, the Europe market is segmented into the following sub-markets with annual revenue ($ mn) for 2019-2030 included in each section. • Pharmaceutical and Biotechnology Companies • Academic and Research Institutes • Cosmetics Industry • Other End Users Geographically, the following national/local markets are fully investigated: • Germany • UK • France • Spain • Italy • Russia • Rest of Europe (further segmented into Netherlands, Switzerland, Poland, Sweden, Belgium, Austria, Ireland, Norway, Denmark, and Finland) For each key country, detailed analysis and data for annual revenue ($ mn) are available for 2019-2030. The breakdown of key national markets by Organ Type, Application, and End User over the forecast years are also included. The report also covers current competitive scenario and the predicted trend; and profiles key vendors including market leaders and important emerging players. Key Players (this may not be a complete list and extra companies can be added upon request): AxoSim Inc. BiomimX SRL Cherry Biotech CN Bio Innovations, Ltd. Emulate Inc. Hurel Corporation InSphero AG Kirkstall, Ltd. MIMETAS BV Nortis Inc. Organovo, Inc. SynVivo, Inc. Tara Biosystems Inc. TissUse GmbH (Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)
Read More